Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anu Gupta

Showing results (181-190 of 185) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 185 results.
Cancer Cell|May 16, 2019
Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA VariantsBryan D Smith, Michael D Kaufman, Wei-Ping Lu, et al.
Annals of Indian Academy of Neurology|January 10, 2022
Clinical Features and Outcome of Stroke with COVID-19. COVID-19 Stroke Study Group (CSSG), IndiaRohit Bhatia, M V Padma Srivastava, P N Sylaja, et al.
Journal of the Neurological Sciences|August 10, 2021
Clinical profile and outcome of non-COVID strokes during pandemic and the pre pandemic period: COVID-Stroke Study Group (CSSG) IndiaRohit Bhatia, P N Sylaja, M V Padma Srivastava, et al.
Annals of Indian Academy of Neurology|October 10, 2022
Study Protocol: IMPETUS: Implementing a Uniform Stroke Care Pathway in Medical Colleges of India: IMPETUS <i>Stroke</i>Rohit Bhatia, Partha Haldar, Inder Puri, et al.
Frontiers in Neurology|December 19, 2025
Assessment of acute stroke care, stroke metrics and patient outcomes: analysis from the pre-implementation phase of the IMPETUS stroke studyShweta Gupta, Rohit Bhatia, Madakasira Vasantha Padma Srivastava, et al.
Pageof 19

Showing results (181-190 of 185) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 185 results.
Cancer Cell|May 16, 2019
Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA VariantsBryan D Smith, Michael D Kaufman, Wei-Ping Lu, et al.
Annals of Indian Academy of Neurology|January 10, 2022
Clinical Features and Outcome of Stroke with COVID-19. COVID-19 Stroke Study Group (CSSG), IndiaRohit Bhatia, M V Padma Srivastava, P N Sylaja, et al.
Journal of the Neurological Sciences|August 10, 2021
Clinical profile and outcome of non-COVID strokes during pandemic and the pre pandemic period: COVID-Stroke Study Group (CSSG) IndiaRohit Bhatia, P N Sylaja, M V Padma Srivastava, et al.
Annals of Indian Academy of Neurology|October 10, 2022
Study Protocol: IMPETUS: Implementing a Uniform Stroke Care Pathway in Medical Colleges of India: IMPETUS <i>Stroke</i>Rohit Bhatia, Partha Haldar, Inder Puri, et al.
Frontiers in Neurology|December 19, 2025
Assessment of acute stroke care, stroke metrics and patient outcomes: analysis from the pre-implementation phase of the IMPETUS stroke studyShweta Gupta, Rohit Bhatia, Madakasira Vasantha Padma Srivastava, et al.
Pageof 19